Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved    

Acamprosate-calcium-TOP

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Active Pharmaceutical Ingredients  TAJ PHARMACEUTICALS LIMITED

Acamprosate calcium Manufacturers in India Suppliers Acamprosate calcium Exporters Distributors Acamprosate calcium api active pharmaceuticals ingredients Acamprosate calcium manufacturers Side Effects bulk drugs raw material Acamprosate calcium companies Side Effects Importers Acamprosate calcium Acamprosate calcium Exporters Acamprosate calcium exporters FDA Acamprosate calcium DMF Symptoms Generic Taj Pharmaceuticals Ltd.

Pharmaceuticals API Manufacturer Acamprosate calcium, Acamprosate calcium manufacturer India, Acamprosate calcium product, Acamprosate calcium products, Api preparation, Certificate of Analysis API manufacturer product, Acamprosate calcium anti ulcer product, Certificate of Origin COA Acamprosate calcium COS Acamprosate calcium, pharmaceutical generic, pharmaceutical drug, medical, Acamprosate calcium pharma healthcare, pharma patents, contract MSDS manufacturing Trader Acamprosate calcium pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Acamprosate calcium expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Acamprosate calcium DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Acamprosate calcium ingredients, api, HIV Acamprosate calcium, tablets, capsules, syrup & protein Acamprosate calcium powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Acamprosate calcium gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Acamprosate calcium WHO, UKMHRA Approval

 
   PRODUCT LIST
   Home
  API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 
taj pharma






















 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

HOME >> API >> API List1 >> Acamprosate Calcium >> Acamprosate Calcium Pharmacology

PI-21684 Acamprosate calcium (77337-73-6)


PI-21684 Acamprosate calcium (77337-73-6)
Acamprosate Calcium Pharmacology

Pharmacology

Chronic alcohol exposure may alter normal balance between neuronal and excitation and inhibition. In vitro and in vivo animal data suggest acamprosate interacts with glutamate and GABA neurotransmitter systems, restoring this balance.

Pharmacokinetics

Absorption

Bioavailability about 11%. Steady state reached within 5 days. Steady-state concentrations average 350 ng/mL and occur 3 to 8 h postdose. C max and AUC approximately 42% and 23%, respectively.

Distribution

Vd estimated to be 72 to 109 L (1 L/kg). Protein binding is negligible.

Metabolism

Does not undergo metabolism.

Elimination

Terminal t ˝ ranges from about 20 to 33 h. Major route of excretion is via kidneys.

Special Populations

Renal function impairment

C max in patients with moderate or severe renal function impairment were 2- and 4-fold higher, respectively. Elimination t ˝ were 1.8- and 2.6-fold longer, respectively.

Indications and Usage

Maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.

Contraindications

Severe renal function impairment (Ccr 30 mL/min or less); hypersensitivity to any component of product.

Dosage and Administration

Adults

PO Two 333 mg tablets 3 times daily.

Renal Function Impairment
Adults

PO Start with 333 mg 3 times daily in patients with moderate renal function impairment (Ccr 30 to 50 mL/min). Do not administer to patients with severe renal function impairment (Ccr 30 mL/min or less).

Storage/Stability

Store tablets at controlled room temperature (59° to 86°F).

   
Information Associated with Product:  
DRUG DESCRIPTION:
  USES:
  HOW TO USE:
SIDE EFFECTS:
  Acamprosate Calcium Pharmacology >>
  Mechanism Of Action:
 
 
 
PDF DOWNLOAD WORD DOCUMENT  
     
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

 

 


Taj Pharmaceuticals API Logo

Acamprosate Calcium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.